150 related articles for article (PubMed ID: 10473082)
21. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity in primary lung cancer using laser capture microdissection and WAVE DNA fragment analysis techniques.
Zhu W; Zou H; Beck A; Chervinsky D; Malik D; Brooks J; Tan D
Med Sci Monit; 2002 Mar; 8(3):BR95-9. PubMed ID: 11889456
[TBL] [Abstract][Full Text] [Related]
24. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
Chmara M; Wozniak A; Ochman K; Kobierska G; Dziadziuszko R; Sosinska-Mielcarek K; Jassem E; Skokowski J; Jassem J; Limon J
Anticancer Res; 2004; 24(6):4259-63. PubMed ID: 15736482
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma.
Yoshino I; Osoegawa A; Yohena T; Kameyama T; Oki E; Oda S; Maehara Y
Respir Med; 2005 Mar; 99(3):308-12. PubMed ID: 15733506
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.
Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578
[TBL] [Abstract][Full Text] [Related]
28. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
29. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
31. [Loss of heterozygosity in the 9p21 region as an inactivation mechanism of the p16 suppressor gene].
Maestro de las Casas ML; Sanz-Casla MT; del Barco V; Moreno J; Zanna I; Redondo E; Fernández C; Izquierdo L; Resel Estévez L
Arch Esp Urol; 2000 Sep; 53(7):603-9. PubMed ID: 11037653
[TBL] [Abstract][Full Text] [Related]
32. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
34. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer.
Hu N; Roth MJ; Emmert-Buck MR; Tang ZZ; Polymeropolous M; Wang QH; Goldstein AM; Han XY; Dawsey SM; Ding T; Giffen C; Taylor PR
Clin Cancer Res; 1999 Nov; 5(11):3476-82. PubMed ID: 10589761
[TBL] [Abstract][Full Text] [Related]
35. Alterations of 9p in squamous cell carcinoma and adenocarcinoma of the lung: association with smoking, TP53, and survival.
Marsit CJ; Wiencke JK; Nelson HH; Kim DH; Hinds PW; Aldape K; Kelsey KT
Cancer Genet Cytogenet; 2005 Oct; 162(2):115-21. PubMed ID: 16213358
[TBL] [Abstract][Full Text] [Related]
36. Deletion mapping of 18q in conventional renal cell carcinoma.
Hirata H; Matsuyama H; Matsumoto H; Korenaga Y; Ohmi C; Sakano S; Yoshihiro S; Naito K
Cancer Genet Cytogenet; 2005 Dec; 163(2):101-5. PubMed ID: 16337851
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.
Grundei T; Vogelsang H; Ott K; Mueller J; Scholz M; Becker K; Fink U; Siewert JR; Höfler H; Keller G
Clin Cancer Res; 2000 Dec; 6(12):4782-8. PubMed ID: 11156235
[TBL] [Abstract][Full Text] [Related]
38. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
Tseng JE; Kemp BL; Khuri FR; Kurie JM; Lee JS; Zhou X; Liu D; Hong WK; Mao L
Cancer Res; 1999 Oct; 59(19):4798-803. PubMed ID: 10519387
[TBL] [Abstract][Full Text] [Related]
39. [Determination of allelic losses in peritumor bronchial mucosa].
Sanz Esponera J
An R Acad Nac Med (Madr); 1999; 116(2):265-72; discussion 273-6. PubMed ID: 10682392
[TBL] [Abstract][Full Text] [Related]
40. [Chromosome marker--2q- during carcinogenesis and development of human lung cancer].
Lü Y; Dong X; Guo S
Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):180-3. PubMed ID: 10920891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
